MedAvante Rolls Out Site Rater Software for CNS Trials


MedAvanta offers software that guides investigative sites in rater reliability skills.

MedAvante, a provider of centralized assessments and quality control in clinical trials of treatments for central nervous system (CNS) disorders, announced the Virgil Investigative Study Platform for use by drug developers and their global cohort of trial sites. It allows clinicians at investigative sites to standardize rating scale administration and scoring across trials. Virgil software ranges from electronic rating scale forms, which provide clinical guidance to site raters as they administer an assessment, to operational workflows throughout the study process.

Link here for the full press release.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.